Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KORTUC as a Radiation Sensitiser in Breast Cancer
NCT03946202Phase 2Active, not recruiting
- Sponsor
- The Institute of Cancer Research
- Start
- Jun 2020
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of hydrogen peroxide in breast cancer, sponsored by The Institute of Cancer Research. Started Jun 2020; status: active, not recruiting.
02
Drugs
hydrogen peroxide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03946202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03946202.